Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,251
datasets available to search
ShareScore release 0.9.0
Dataset results
3,251 results for “ovarian cancer”
Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer
ClinicalTrials.gov study NCT00719212. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment
ClinicalTrials.gov study NCT02035345. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT00903630. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy
ClinicalTrials.gov study NCT00189358. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT01540565. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ovarian Cancer Patient-Centered Decision Aid
ClinicalTrials.gov study NCT02259699. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT07265739. IPD Sharing: YES. Countries: 1. Publications: 0.
SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin
ClinicalTrials.gov study NCT01200797. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
ClinicalTrials.gov study NCT05708924. IPD Sharing: NO. Countries: 1. Publications: 0.
MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer
ClinicalTrials.gov study NCT02364713. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
ClinicalTrials.gov study NCT07023627. IPD Sharing: YES. Countries: 8. Publications: 0.
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT04204811. IPD Sharing: YES. Countries: 1. Publications: 0.
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
ClinicalTrials.gov study NCT00191646. IPD Sharing: Not stated. Countries: 2. Publications: 0.
EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT01118052. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT02311907. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT03602859. IPD Sharing: NO. Countries: 19. Publications: 0.
SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084)
ClinicalTrials.gov study NCT00002960. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT01744821. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bioequivalence Study of SPARC147609 in Patients With Ovarian Cancer
ClinicalTrials.gov study NCT00862355. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers
ClinicalTrials.gov study NCT00319748. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.